Marion Pierre

Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy

X. Nissan, H. Delanoe-Ayari, A. Meli, 2021, Clinical and translational medicine.

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons

F. Calon, V. Émond, E. Fon, 2022, Scientific Reports.

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

J. Puymirat, M. Chahine, Marion Pierre, 2021, Neurobiology of Disease.

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

J. Puymirat, F. Rigo, C. Bennett, 2022, Gene therapy.

Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.

M. Boutjdir, J. Puymirat, M. Chahine, 2023, Stem cell research.

Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels

M. Boutjdir, Mohammed Djemai, Marion Pierre, 2023, Frontiers in physiology.